$APVO Wow wow wow Ok let me just throw this thought out there. I don’t see the ADA thing being an issue and I think they’re sandbagging data. Why would BEAT AML add them right now to the study with critical P1 data readouts 1-2 months away? This is a $5 stock with collaborations and/or upfront money. Annnnnnnd if 436 works what interest do they get with Alg.Apv or 603? 👀😲
  • 6
  • 2